SHIRE PHARMACEUTICALS LLC for SHIRE PHARMACEUTICALS LLC
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report | Jul 20, 2018 | $540,000 | Replaced |
| 2nd Quarter - Amendment (this page) | Jul 26, 2018 | $540,000 | Yes |
What was lobbied
7 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Committee on Foreign Investment in the United States (CFIUS) reform
| Lobbyist | Covered position, as disclosed |
|---|---|
| JED PERRY | — |
Taxation/Internal Revenue Code TAX
Orphan drug tax credit
| Lobbyist | Covered position, as disclosed |
|---|---|
| JED PERRY | — |
Foreign Relations FOR
HR 4170: Disclosing Foreign Influence Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| JED PERRY | — |
Copyright/Patent/Trademark CPT
HR 5340/S1390: Stronger Patents Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| JED PERRY | — |
Health Issues HCR
HR 2587/S1194: Medical Nutrition Equity Act of 2017 HR6: Support for Patients and Communities Act 340B Drug Discount Program Orphan Drug Act Gene Therapy Drug Pricing
| Lobbyist | Covered position, as disclosed |
|---|---|
| ENGEL BURNS | — |
| JED PERRY | — |
Medicare/Medicaid MMM
- Home Infusion technical change to H.R.6 21st Century Cures to move wrap around training and monitoring services benefit forward from 2021 to 2018 implementation. - Medicare coverage and reimbursement - Medicare Part B drug payment model demonstration - HR 4724: Medicare IVIG Access Enhancement Act - Medicare Part D
| Lobbyist | Covered position, as disclosed |
|---|---|
| ENGEL BURNS | — |
| JED PERRY | — |
Pharmacy PHA
ADHD Awareness *Drug Values -DEA processes and re-exportation -FDA Funding -Medicaid rare disease patient access to therapy Patient access to therapy, including Medicaid, Medicare, and insurance. -Orphan Drug Act regulations -Expanded Access -Rare Disease awareness -Right to Try legislation (S. 204, H.R. 878, and H.R. 2368) -Newborn Screening
| Lobbyist | Covered position, as disclosed |
|---|---|
| ENGEL BURNS | — |
| JED PERRY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.